PortfoliosLab logoPortfoliosLab logo
SOF.BR vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SOF.BR vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Sofina Société Anonyme (SOF.BR) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

SOF.BR is traded in EUR, while NVO is traded in USD. To make them comparable, the NVO values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, SOF.BR achieves a -11.22% return, which is significantly lower than NVO's -9.37% return. Over the past 10 years, SOF.BR has outperformed NVO with an annualized return of 8.03%, while NVO has yielded a comparatively lower 7.22% annualized return.


SOF.BR

1D
2.26%
1M
0.78%
YTD
-11.22%
6M
-7.94%
1Y
-13.53%
3Y*
3.50%
5Y*
-8.43%
10Y*
8.03%

NVO

1D
-0.10%
1M
-1.42%
YTD
-9.37%
6M
-8.16%
1Y
-42.56%
3Y*
-17.53%
5Y*
3.87%
10Y*
7.22%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SOF.BR vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SOF.BR
Sofina Société Anonyme
-11.22%14.69%-1.65%11.37%-51.86%57.47%45.71%17.99%28.74%6.68%
NVO
Novo Nordisk A/S
-9.37%-46.43%-10.38%50.20%30.26%75.75%13.17%31.61%-8.89%34.13%

Correlation

The correlation between SOF.BR and NVO is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Sep 7, 2007

0.17

The correlation between SOF.BR and NVO shifts across timeframes, from 0.06 (3 years) to 0.17 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SOF.BR vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOF.BR
SOF.BR Risk / Return Rank: 1717
Overall Rank
SOF.BR Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
SOF.BR Sortino Ratio Rank: 1515
Sortino Ratio Rank
SOF.BR Omega Ratio Rank: 1515
Omega Ratio Rank
SOF.BR Calmar Ratio Rank: 2121
Calmar Ratio Rank
SOF.BR Martin Ratio Rank: 2020
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOF.BR vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sofina Société Anonyme (SOF.BR) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SOF.BRNVODifference
Sharpe ratioReturn per unit of total volatility

+0.16

Sortino ratioReturn per unit of downside risk

+0.22

Omega ratioGain probability vs. loss probability

0.90

0.85

+0.05

Calmar ratioReturn relative to maximum drawdown

-0.61

-0.80

+0.19

Martin ratioReturn relative to average drawdown

-1.08

-1.16

+0.08

SOF.BR vs. NVO - Sharpe Ratio Comparison

The current SOF.BR Sharpe Ratio is -0.69, which is comparable to the NVO Sharpe Ratio of -0.85. The chart below compares the historical Sharpe Ratios of SOF.BR and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SOF.BR vs. NVO - Drawdown Comparison

The maximum SOF.BR drawdown since its inception was -59.53%, smaller than the maximum NVO drawdown of -76.45%. Use the drawdown chart below to compare losses from any high point for SOF.BR and NVO.


Loading charts...

Drawdown Indicators


SOF.BRNVODifference

Max Drawdown

Largest peak-to-trough decline

-59.53%

-76.45%

+16.92%

Max Drawdown (1Y)

Largest decline over 1 year

-26.62%

-54.18%

+27.56%

Max Drawdown (3Y)

Largest decline over 3 years

-26.62%

-76.45%

+49.83%

Max Drawdown (5Y)

Largest decline over 5 years

-59.53%

-76.45%

+16.92%

Max Drawdown (10Y)

Largest decline over 10 years

-59.53%

-76.45%

+16.92%

Current Drawdown

Current decline from peak

-46.64%

-70.47%

+23.83%

Average Drawdown

Average peak-to-trough decline

-19.13%

-13.82%

-5.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.02%

38.02%

-23.00%

Volatility

SOF.BR vs. NVO - Volatility Comparison

The current volatility for Sofina Société Anonyme (SOF.BR) is 6.23%, while Novo Nordisk A/S (NVO) has a volatility of 10.26%. This indicates that SOF.BR experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SOF.BRNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

6.23%

10.26%

-4.03%

Volatility (6M)

Calculated over the trailing 6-month period

16.85%

37.42%

-20.57%

Volatility (1Y)

Calculated over the trailing 1-year period

23.40%

50.86%

-27.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.53%

38.01%

-9.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.81%

32.48%

-7.67%

Dividends

SOF.BR vs. NVO - Dividend Comparison

SOF.BR's dividend yield for the trailing twelve months is around 1.18%, less than NVO's 4.11% yield.


PositionTTM20252024202320222021202020192018201720162015
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
SOF.BR
Sofina Société Anonyme
1.18%1.41%1.53%1.44%1.52%0.70%1.05%1.45%1.61%1.95%1.96%2.21%

Financials

SOF.BR vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Sofina Société Anonyme and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. SOF.BR values in EUR, NVO values in DKK

Frequently Asked Questions


SOF.BR and NVO have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for SOF.BR and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer